This trial is testing how well electronic neurocognitive tools can screen for mental capability in patients who are undergoing liver surgery. The hope is that these tools will be able to better assess mental impairment.
8 Primary · 0 Secondary · Reporting Duration: Up to 1 year
Active Control
Experimental Treatment
100 Total Participants · 2 Treatment Groups
Primary Treatment: BrainCheck Cognitive Assessment · No Placebo Group · N/A
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: